Inozyme Pharma To Present Recently Announced Data From Phase 1/2 Trials Of INZ-701 In Adults With ENPP1 Deficiency And ABCC6 Deficiency (PXE) At Upcom...
BOSTON, May 23, 2024 (GLOBE NEWSWIRE) --
Source: menafn.com
Trial Design News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Trial Design. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Trial Design Today - Breaking & Trending Today
Clinical Trial Imaging Market Set for Exceptional Growth, 7.8% CAGR Expected | Market.us
Market OverviewThe Clinical Trial Imaging Market was valued at USD 1,150.5 Million in 2023 and projected to more than double to reach USD 2,219.8 Million by 2032. This market is expected to expand at a Compound Annual Growth Rate (CAGR) of 7.8% from 2023 to 2032. The substantial growth can be attributed to several f...
Source: pharmiweb.com
One2Treat: can it transfrom clinical research?
Today (March 26) One2Treat, a progressive startup specializing in digital health solutions, has launched a forward-thinking approach aimed at tackling key challenges in the biopharma industry.
Source: outsourcing-pharma.com
Implementing Bispecific Antibodies in Lymphoma Care
Experts provide practical guidelines and key takeaways for health care professionals and policymakers on the implementation of bispecific antibodies in DLBCL (diffuse large B cell lymphoma), emphasizing safety, efficacy, and operational strategies.
Source: pharmacytimes.com
Unmet Needs in Bispecific Therapy Access
A panel of experts examines unmet needs in the adoption of bispecific antibody therapy, emphasizing the importance of access and education for diverse stakeholders in oncology care to improve patient outcomes.
Source: pharmacytimes.com